JNJ : Analysis & Opinions
November 16, 2006Despite BMY's recent struggles with its Plavix sales, favorable demographics make the stock a good investment to consider.
November 8, 2006Boston Scientific looks poised for higher per share valuations in the future.
July 18, 2006With an economic slowdown in the mix, Target may feel the pinch more than investors expect.
June 12, 2006$15 billion for its consumer products unit won’t cure Pfizer’s ailing stock.